Microbot Medical Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +75.0% | -20.0% | -50.0% | +64.3% | +13.0% | -42.3% | -20.0% | -16.7% | +0.0% | +20.0% | +25.0% | – | |
| – | -11.6% | +52.5% | -26.9% | -14.5% | -0.4% | -9.2% | -7.4% | +38.4% | -28.0% | -5.9% | +95.0% | – | |
| – | -64.8% | -529.8% | – | – | +815.8% | -94.8% | +991.8% | -155.1% | – | – | – | – | |
| – | -82.1% | +180.0% | -71.4% | -100.0% | – | +85.7% | -30.8% | +44.4% | +92.3% | +332.0% | +31.5% | – | |
| – | – | -143.4% | – | -88.2% | +967.9% | -1,760.9% | -94.7% | +3,315.7% | -96.6% | – | -10.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3,973.3% | – | -13.5% | -69.5% | +347.4% | +881.9% | -82.9% | +976.9% | -95.1% | -100.0% | – | – | |
| – | – | -215.1% | – | -252.4% | – | -96.1% | +752.9% | +201.5% | -206.2% | – | -167.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.